Skip to content

Cannabis research published in 2020

Page 2 of 5: studies 21 to 40 of 92, newest first. Back to the cannabis overview

Studies

FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder

Brain and Behavior August 30, 2020 Natalia M Kleinhans, Julia Sweigert, Matthew Blake et al.

The smell of cannabis is a cue with universal relevance to cannabis users. However, most cue reactivity imaging studies have solely utilized visual images, auditory imagery scripts, or tactile cues in their experiments. This study introduces a multimodal cue reactivity paradigm that includes picture, odor, and bimodal picture + odor cues.

Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies.

BMC Psychiatry August 26, 2020 Ana Maria Raymundi, Thiago R Da Silva, Jeferson M B Sohn et al.

Posttraumatic stress disorder (PTSD) may stem from the formation of aberrant and enduring aversive memories. Some PTSD patients have recreationally used Cannabis, probably aiming at relieving their symptomatology. However, it is still largely unknown whether and how Cannabis or its psychotomimetic compound Δ9-tetrahydrocannabinol (THC) attenuates the aversive/traumatic memory outcomes. Here, we...

The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.

Psychiatry Research August 23, 2020 Chloé de Vos, Karolina Leopold, Elisabeth S. Blanke et al.

Cannabis use is highly prevalent among young people diagnosed with first-episode psychosis (FEP), however, its impact on cognition is still unclear. The aim of the present study was to examine the association of cannabis use with cognition in people diagnosed with FEP. We extended previous research findings by operationalising the comorbid cannabis use, considering recency of cannabis use and...

Evidence That Cannabis Exposure, Abuse, and Dependence Are Related to Glutamate Metabolism and Glial Function in the Anterior Cingulate Cortex: A 1H-Magnetic Resonance Spectroscopy Study

Frontiers in Psychiatry August 20, 2020 Jeremy J. Watts, Ranjini Garani Ramesh, Tânia Maria Sarmento Silva et al. 21 citations

There is evidence that long-term cannabis use is associated with alterations to glutamate neurotransmission and glial function. In this study, twenty-six long-term cannabis users (males=65.4%) and 47 non-cannabis using healthy controls (males=44.6%) underwent proton magnetic resonance spectroscopy (1H-MRS) of the anterior cingulate cortex (ACC) in order to characterize neurometabolite...

DOI: 10.3389/fpsyt.2020.00764 (opens in new tab) Cannabis Glutamate receptor Glutamine Anterior cingulate cortex +4

[The political uses of prohibitionist "science:" The case of cannabis and psychedelics].

Salud Colectiva August 19, 2020 David Pere Martínez Oró, Ismael Apud, Juan Scuro et al. 12 citations

This article analyzes the use of science as a political tool in prohibitionist logic, adopting an externalist perspective. Prohibitionism strives to have its political-moral precepts be considered scientific, that is, the result of an ideologically neutral research process. The article analyzes the case of cannabis and psychedelics to show how prohibitionism has only resorted to "science" to...

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Journal of Visualized Experiments August 18, 2020 Giuseppe Delvecchio, Lucio Oldani, Gian Mario Mandolini et al. 3 citations

Cannabis is the illicit drug most commonly used worldwide, and its consumption can both induce psychiatric symptoms in otherwise healthy subjects and unmask a florid psychotic picture in patients with a prior psychotic risk. Previous studies suggest that chronic and long-term cannabis exposure may exert significant negative effects in brain areas enriched with cannabinoid receptors. However,...

First break psychosis in a young military veteran with cannabis use disorder: an educational case report

International journal of adolescent medicine and health August 18, 2020 Paulina Riess, Leo Sher

Abstract: Psychotropic management of a first psychotic break is challenging for many psychiatrists. The literature shows that the use of cannabis is widespread in psychotic individuals. The literature also points to young males being most at risk for substance abuse. Studies also show that obstructive sleep apnea and the stress of the military lifestyle contribute to the development of...

Psychosis caused by cannabis: Intoxication or induced?

Alcoholism & Drug Abuse Weekly August 10, 2020 Alison Knopf

Telling the difference between primary psychosis, cannabis intoxication and cannabis‐induced psychosis is challenging but important, especially now that it's known that almost 50% of cannabis‐induced psychosis precedes primary psychosis. A fictional case study reported in Paediatrics & Child Health makes these challenges come to life. But the purpose of the case study is only as an introduction...

The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers

Journal of Psychopharmacology August 5, 2020 Will Lawn, J. P. Hill, Chandni Hindocha et al. 23 citations

BACKGROUND: Cannabidiol has potential therapeutic benefits for people with psychiatric disorders characterised by reward function impairment. There is existing evidence that cannabidiol may influence some aspects of reward processing. However, it is unknown whether cannabidiol acutely affects brain function underpinning reward anticipation and feedback. HYPOTHESES: We predicted that cannabidiol...

DOI: 10.1177/0269881120944148 (opens in new tab) Cannabidiol Cannabis Anticipation artificial intelligence Incentive salience +3

Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.

Experimental and Clinical Psychopharmacology August 1, 2020 M. Lovell, Jane Akhurst, C. Padgett et al.

Despite research advances, it remains unclear if long-term, regular cannabis use harms cognition once intoxication has passed. Our meta-analysis aimed to investigate the association between cognitive functioning and long-term (mean ≥2 years), regular (mean ≥4 days/week), recreational cannabis use in adults during abstinence (mean ≥12 hr). We searched PubMed, PsycINFO, CINAHL, Scopus, and...

Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.

Depression and Anxiety August 1, 2020 Reilly R Kayser, Margaret Haney, Marissa Raskin et al.

Preclinical data implicate the endocannabinoid system in the pathology underlying obsessive-compulsive disorder (OCD), while survey data have linked OCD symptoms to increased cannabis use. Cannabis products are increasingly marketed as treatments for anxiety and other OCD-related symptoms. Yet, few studies have tested the acute effects of cannabis on psychiatric symptoms in humans. We recruited...

Effects of Chronic Exposure to Low-Dose delta-9-Tetrahydrocannabinol in Adolescence and Adulthood on Serotonin/Norepinephrine Neurotransmission and Emotional Behavior

The International Journal of Neuropsychopharmacology July 23, 2020 Danilo de Gregorio, Joshua Dean Conway, Martha López-canul et al. 39 citations

BACKGROUND: Chronic exposure to the Δ9-tetrahydrocannabinol (THC), the main cannabis pharmacological component, during adolescence has been shown to be associated with an increased risk of depression and suicidality in humans. AIMS: Little is known about the impact of the long-term effects of chronic exposure to low doses of THC in adolescent compared to adult rodents. METHODS: THC (1mg/kg...

Executive Functions and Cannabis Use in Adolescents

Preprints.org July 22, 2020 Alessandro Frolli, Maria Carla Ricci, Antonella Cavallaro et al. 3 citations preprint

The developmental phase of adolescence is characterized by a multitude of neurocognitive and psychosocial changes and is therefore considered one of the most critical developmental periods of life. Experimentation on the use of substances often begins in adolescence and so does the addiction process. Most research in human subjects shows that chronic cannabis abuse is the cause of the...

The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review

Cureus July 21, 2020 Shweta Patel, Sahar Khan, M Saipavankumar et al. 69 citations

Marijuana is one of the most abused substances in the world. Marijuana is getting legalized around the world. So, it is crucial to understand its effect on our mental health. Its impact on the schizophrenia spectrum needs our special attention. Even though marijuana has been around for a long time, its exact effects are still unknown. Schizophrenia is a chronic illness affecting approximately...

Relationship among subjective responses, flavor, and chemical composition across more than 800 commercial cannabis varieties

Journal of Cannabis Research July 17, 2020 Laura Alethia de la Fuente, Federico Zamberlán, Andrés Sánchez Ferrán et al. 30 citations

BACKGROUND: Widespread commercialization of cannabis has led to the introduction of brand names based on users' subjective experience of psychological effects and flavors, but this process has occurred in the absence of agreed standards. The objective of this work was to leverage information extracted from large databases to evaluate the consistency and validity of these subjective reports, and...

DOI: 10.1186/s42238-020-00028-y (opens in new tab) Cultivar Categorization Flavour Terpenoid +9

The short-term and long-term effects of cannabis on cognition: recent advances in the field.

Current Opinion in Psychology July 16, 2020 Emese Kroon, Lauren Kuhns, Janna Cousijn

The aim of this review is to discuss the most recent evidence for the short-term and long-term effects of cannabis on cognition. The evidence that cannabis intoxication is associated with short-term impairment across several basal cognitive domains, including learning and (episodic) memory, attentional control, and motor inhibition is increasing. However, evidence regarding the effects of...

Psicosis inducida por cannabis: características clínicas y su diferenciación con la esquizofrenia con y sin consumo de cannabis asociado

Adicciones July 14, 2020 David Rentero Martín, F. Árias, Sergio Sánchez-Romero et al. 13 citations

Cannabis use is considered an established risk factor for psychosis development. Differentiating between cannabis-induced disorders and schizophrenia is useful for prognostic and therapeutic purposes. Three inpatients groups were differentiated: cannabis-induced psychosis (CIP) (n = 69; mean age = 27.4, SD = 6.5; 82.6% males), schizophrenia with cannabis abuse or dependence (SZ + CB) (n = 57;...

DOI: 10.20882/adicciones.1251 (opens in new tab) Cannabidiol Psychosis Schizophrenia object-oriented programming Mania +3

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

Frontiers in Psychiatry July 7, 2020 Michael Specka, Thomas Kuhlmann, Jürgen Sawazki et al. 42 citations

Background About 15 years ago, a diverse group of new recreational psychotropic substances began to emerge, which were marketed for example as “legal highs,” “research chemicals,” or “designer drugs.” These substances were later subsumed under the label “Novel Psychoactive Substances” (NPS). Important NPS classes are cathinones, synthetic cannabimimetics, phenethylamines, and herbal drugs. The...

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder

Frontiers in Psychiatry July 2, 2020 Attila Szabo, Ibrahim A. Akkouh, Thor Ueland et al. 12 citations

The complex effects of plant cannabinoids on human physiology is not yet fully understood, but include a wide spectrum of effects on immune modulation. The immune system and its inflammatory effector pathways are recently emerging as possible causative factors in psychotic disorders. The present study aimed to investigate whether self-administered cannabis use was associated with changes in...

Possible therapeutic applications of cannabis in the neuropsychopharmacology field.

European Neuropsychopharmacology July 2020 Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo et al.

Cannabis use induces a plethora of actions on the CNS via its active chemical ingredients, the so-called phytocannabinoids. These compounds have been frequently associated with the intoxicating properties of cannabis preparations. However, not all phytocannabinoids are psychotropic, and, irrespective of whether they are psychotropic or not, they have also shown numerous therapeutic properties....